Yuchao Jin, PA
Medical · San Diego, CANPI 1518454396
Payments from drug & device makers
Across 1,049 payments — averaging $20.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- AbbVie$4K
- UCB, Inc.$2K
- Johnson & Johnson$2K
- Novartis$1K
- GSK$1K
- plus $7K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 227 | $4,372 |
| AbbVie | 234 | $4,323 |
| UCB, Inc. | 103 | $2,211 |
| Johnson & Johnson | 82 | $2,035 |
| Novartis | 70 | $1,231 |
| GSK | 57 | $1,191 |
| Lilly USA, LLC | 36 | $924 |
| AstraZeneca(2 entities) | 48 | $923 |
| Mallinckrodt Hospital Products Inc. | 30 | $888 |
| Aurinia Pharma U.S., Inc. | 37 | $826 |
| Boehringer Ingelheim | 15 | $518 |
| Radius Health, Inc. | 16 | $312 |
| Pfizer | 18 | $293 |
| ANI Pharmaceuticals, Inc. | 11 | $252 |
| Sanofi | 7 | $182 |
| Kyowa Kirin, Inc. | 4 | $177 |
| Scilex Pharmaceuticals Inc. | 7 | $159 |
| Genentech USA, Inc. | 6 | $134 |
| Janssen Scientific Affairs, LLC | 1 | $117 |
| Actelion Pharmaceuticals US, Inc. | 7 | $116 |
| Alnylam Pharmaceuticals Inc. | 4 | $109 |
| Antares Pharma, Inc. | 6 | $87 |
| Biocryst US Sales Co., LLC | 2 | $73 |
| Sandoz | 4 | $71 |
| Cumberland Pharmaceuticals, Inc. | 2 | $58 |
| E.r. Squibb & Sons, L.L.C. | 1 | $42 |
| Novo Nordisk | 2 | $40 |
| Celltrion USA Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $31 |
| Biogen | 1 | $25 |
| Sobi, Inc | 1 | $25 |
| Echosens North America, Inc. | 1 | $22 |
| Tonix Medicines, Inc. | 1 | $21 |
| CSL Behring | 1 | $19 |
| Eisai Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Fresenius Kabi USA, LLC | 1 | $16 |
How this compares
$21,914 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical in San Diego
- Cheryl KyinnSan Diego$103K
- Touraj YariSan Diego$27K
- Aaron WillcottSan Diego$23K
- Carter CopelandSan Diego$17K
- Cameron ChanSan Diego$16K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.